Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: Risk factors and association with mortality

  • Diana Averbuch
  • Gloria Tridello
  • Jennifer Hoek
  • Malgorzata Mikulska
  • Thomas Pabst
  • Lucrecia Yaňez San Segundo
  • Hamdi Akan
  • Tülay Özçelik
  • Irene Donnini
  • Galina Klyasova
  • Aida Botelho de Sousa
  • Tsila Zuckerman
  • Cristina Tecchio
  • Rafael de la Camara
  • Sahika Zeynep Aki
  • Per Ljungman
  • Zafer Gülbas
  • Emmanuelle Nicolas-Virelizier
  • Elisabetta Calore
  • Katia Perruccio
  • Ron Ram
  • Claudio Annaloro
  • Rodrigo Martino
  • Batia Avni
  • Peter J Shaw
  • Alexandra Jungova
  • Katia Codeluppi
  • Tracey O'Brien
  • Anna Waszczuk-Gajda
  • Montserrat Batlle
  • Anastasia Pouli
  • Catherina Lueck
  • Lidia Gil
  • Simona Iacobelli
  • Jan Styczynski
  • Dan Engelhard (Shared last author)
  • Simone Cesaro (Shared last author)

Abstract

OBJECTIVES: We present here data on Gram-negative rods bacteremia (GNRB) rates, risk factors and associated mortality.

METHODS: Data on GNRB episodes were prospectively collected in 65 allo-/67 auto-HSCT centers in 24 countries (Europe, Asia, Australia). In patients with and without GNRB, we compared: demography, underlying disease, HSCT-related data, center` fluoroquinolone prophylaxis (FQP) policy and accreditation status, and involvement of infection control team (ICT).

RESULTS: The GNRB cumulative incidence among 2818 allo-HSCT was: pre-engraftment (pre-eng-allo-HSCT), 8.4 (95% CI 7-9%), post-engraftment (post-eng-allo-HSCT), 5.8% (95%CI: 5-7%); among 3152 auto-HSCT, pre-eng-auto-HSCT, 6.6% (95%CI: 6-7%), post-eng-auto-HSCT, 0.7% (95%CI: 0.4-1.1%). GNRB, especially MDR, was associated with increased mortality. Multivariate analysis revealed the following GNRB risk factors: (a) pre-eng-allo-HSCT: south-eastern Europe center location, underlying diseases not at complete remission, and cord blood source; (b) post-eng-allo-HSCT: center location not in northwestern Europe; underlying non-malignant disease, not providing FQP and never accredited. (c) pre-eng-auto-HSCT: older age, autoimmune and malignant (vs. plasma cell) disease, and ICT absence.

CONCLUSIONS: Benefit of FQP should be explored in prospective studies. Increased GNRB risk in auto-HSCT patients transplanted for autoimmune diseases is worrying. Infection control and being accredited are possibly protective against bacteremia. GNRB are associated with increased mortality.

Bibliographical data

Original languageEnglish
ISSN0163-4453
DOIs
Publication statusPublished - 12.2020
Externally publishedYes

Comment Deanary

Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

PubMed 33186673